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Abstract
Background: In our previous study, we demonstrated that local injection of complement C5a and C3a produce
mechanical and heat hyperalgesia, and that C5a and C3a activate and sensitize cutaneous nociceptors in normal
skin, suggesting a contribution of complement fragments to acute pain. Other studies also have shown that the
complement system can be activated by surgical incision, and the systemic blockade of C5a receptor (C5aR)
reduces incision-induced pain and inflammation. In this study, we further examined the possible contribution of
wound area C5a to incisional pain.
Methods: Using of a hind paw incisional model, the effects of a selective C5aR antagonist, PMX53, on nociceptive
behaviors were measured after incision in vivo. mRNA levels of C5 and C5aR in skin, dorsal root ganglia (DRG) and
spinal cord, and C5a protein levels in the skin were quantified after incision. The responses of nociceptors to C5a
were also evaluated using the in vitro skin-nerve preparation.
Results: Local administration of PMX53 suppressed heat hyperalgesia and mechanical allodynia induced by C5a
injection or after hind paw incision in vivo. mRNA levels of C5 and C5aR in the skin, but not DRG and spinal cord,
were dramatically increased after incision. C5a protein in the skin was also increased after incision. In vitro C5a did
not increase the prevalence of fibers with ongoing activity in afferents from incised versus control, unincised skin.
C5a sensitized C-fiber afferent responses to heat; however, this was less evident in afferents adjacent to the
incision. PMX53 blocked sensitization of C-fiber afferents to heat by C5a but did not by itself influence ongoing
activity or heat sensitivity in afferents innervating control or incised skin. The magnitude of mechanical responses
was also not affected by C5a in any nociceptive fibers innervating incised or unincised skin.
Conclusions: This study demonstrates that high locally generated C5a levels are present in wounds for at least 72
hours after incision. In skin, C5a contributes to hypersensitivity after incision, but increased responsiveness of
cutaneous nociceptors to C5a was not evident in incised skin. Thus, high local concentrations of C5a produced in
wounds likely contribute to postoperative pain.
Background
The complement system is a biochemical cascade within
the immune system most commonly associated with the
enhancement of inflammation and direct attack of
foreign organisms. Upon activation of the complement
system, split fragments C5a and C3a augment inflamma-
tory responses, e.g. increase blood flow and vascular
permeability and facilitate migration of neutrophils and
monocytes to the inflamed tissues. C5a and C3a also
induce mast cells to release histamine and tumor
necrosis factor-a (TNF-a), which contribute to the pro-
liferation of the inflammatory response [1-4]. Other
components of the local inflammatory response have
been recognized to play roles in pain including cyto-
kines, neuropeptides and neurotrophins [5]. Comple-
ment fragments such as C5a may share this property.
Our previous study showed that local injection of
complement C5a and C3a produce mechanical and heat
hyperalgesia in vivo, and that C5a and C3a activate and
sensitize cutaneous nociceptors in normal skin in vitro
[6], suggesting complement fragments may contribute to
pain. Furthermore, it has been shown that the comple-
ment system can be activated by surgical incision [7-9],
and the systemic blockade of C5a receptor (C5aR)
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reduces incisional allodynia, edema and cytokine expres-
sion [10] implying a significant contribution of C5a to
the inflammation and pain caused by incision.
Additional studies demonstrate that nociceptors
immediately adjacent to the incision sequester NGF,
have increased heat sensitivity and increase acid respon-
siveness [11-14]. However, important questions like
whether sensitivity to complement fragments is altered
in incised tissue or whether local populations of C5aR
support incisional pain behaviors have remained unan-
swered. In this study, we tested whether the selective
C5aR antagonist PMX53 can reduce incisional nocicep-
tion when injected into peri-incisional skin in vivo, and
if the responses of nociceptors to C5a are enhanced in
incised skin when applied on the peripheral nociceptor
terminals in vitro. We also examined whether the
mRNA levels of C5 and C5aR are altered in skin, dorsal
root ganglia (DRG) and spinal cord by incision in an
attempt to further localize the likely site of action of
C5a in supporting nociception after incision. C5a pro-




Male C57BL/6J mice (20-30 g and 6-12 weeks of age,
Jackson Labs) that were housed in groups of 4-5 were
used. Food and water available ad libitum under a 12-h
light/dark cycle. Experimental protocols were approved
by The Animal Care and Use Committees of the
University of Iowa and the VA Palo Alto Health Care
System.
Drug preparation and administration
Recombinant mouse C5a was purchased from R&D
Systems, Inc. (Minneapolis, MN). The selective C5aR
antagonist PMX53 (AcF-[OPdChaWR]) was the kind
gift of Promics (Queensland, Australia). All drugs were
dissolved in sterile 0.9% normal saline prior to use [10],
and the PBS-vehicle was prepared in the same manner
without adding drug.
For local injection of C5aR antagonist in the incisional
model, injection (30 μg/15 μl) was performed 1 hour
prior to paw incision. The same administration protocol
was repeated 2 hours before each test session in the
time course studies. The 2 hour time point was the
point of maximal analgesic effect as determined in preli-
minary studies. For studies involving antagonism of the
direct local effects of C5a, intraplantar injection of 10 μl
C5a solution (200 ng) was accomplished using a 30
gauge needle and a microsyringe (Hamilton, Reno, NV).
In these studies involving the systemic administration of
C5aR antagonist, the concentration of PMX53 was
adjusted so that a 3 mg/kg dose could be administered
subcutaneously in the skin of the back in a 100 μl
volume; PMX53 was administered 30 minutes prior to
local C5a administration. This dose of PMX53 had been
shown to be effective and selective in other studies
[10,15]. Vehicle injections were used in all studies.
In the electrophysiology study, we tested C5a 0.1 and
1 μg/ml. Because only one concentration of C5a could
be applied to each fiber, full dose-response curves were
not attempted. The higher concentration sensitized C-
fibers to heat in normal skin in our previous study [6].
The lower C5a concentration was included in this study
to determine if there were enhanced responses in
incised tissue. To ensure C5aR antagonism in the in
vitro preparation, 0.9 μg/ml (1 μM) PMX53 was selected
based on previous observations evaluating the potency
of this compound in blocking C5a-induced leukocyte
activation [16].
Surgical incision
Mice were anesthetized with 1.5-2.0% isoflurane deliv-
ered through a nose cone, and the hindpaw of mouse
was sterilized with 10% povidone-iodine. Plantar incision
of hind paw in mice was performed as described pre-
viously by our labs [10,17-19]. Briefly, a 0.5 cm incision
was made through skin and fascia of the plantar hind-
paw with a number 11 scalpel blade. The incision was
started 0.2 cm from the proximal edge of the heel and
extended distally. The underlying muscle was elevated
with curved forceps, leaving the muscle origin and inser-
tion intact. After hemostasis, the wound edges were
opposed with a single 6.0 nylon mattress suture and the
wound was covered with antibiotic ointment. For hairy
skin incision, 0.5 cm incision was made with a number
11 surgical blade on the dorso-medial skin of the left
hindpaw in the area innervated by the saphenous nerve.
The skin was then closed with two subcutaneous mat-
tress sutures with 6-0 nylon and covered with an anti-
biotic ointment. In some cases, the skin from both the
left and right hindpaws were incised and utilized to
minimize the number of animals required for the fiber
recordings. In both plantar and hairy skin incision, con-
trol mice without incision underwent a sham procedure
that consisted of anesthesia, antiseptic preparation, and




Mechanical nociceptive thresholds were assayed using
von Frey filaments according to the “up-down” algo-
rithm described by Chaplan et al. [20] as we described
previously [21,22]. Mice were placed on wire mesh plat-
forms in clear cylindrical plastic enclosures of 10 cm
diameter and 30 cm height. After 20 minutes of
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acclimation, von Frey fibers of sequentially increasing or
decreasing stiffness were applied to the plantar surface
of the right hindpaw and left in place for 5s using suffi-
cient force to slightly bend the filament. Withdrawal of
the hindpaw from the fiber was scored as a response.
When no response was obtained, the next higher force
in the series was applied to the same paw. If a response
was obtained, a less stiff fiber was next applied. Testing
proceeded in this manner until 4 fibers had been applied
after the first one causing a withdrawal response allow-
ing the estimation of the mechanical withdrawal thresh-
old using a curve fitting algorithm [23].
Heat hyperalgesia
Paw withdrawal response latencies to noxious heat sti-
mulation were measured using the method of Har-
greaves et al. [24] as we have modified for use with
mice [21]. In this assay, mice were placed on a tempera-
ture-controlled glass surface (29°C) in a clear plastic
enclosure similar to those described for mechanical test-
ing. After 30 min of acclimation, a beam of focused
light was directed towards the same area of the hindpaw
as described for the von Frey assay. A 20 s cutoff was
used to prevent tissue damage. In these experiments,
the light beam intensity was adjusted to provide an
approximate 10 s baseline latency in control mice.
Three measurements were made per animal per test ses-
sion separated by at least one minute.
Analysis of C5 and C5aR mRNA
Mice were sacrificed at specific time points by CO2
asphyxiation. The skin tissue surrounding the incision
with approximate 1.5-mm margins was excised. Spinal
cord lumbar segments (L3-S1) were harvested by extru-
sion and rapid dissection on a pre-chilled surface. Dor-
sal root ganglia (DRG) were dissected using low power
binocular magnification. All tissues were quick frozen in
liquid nitrogen and stored at -80°C.
For RNA and real-time polymerase chain reaction
(PCR), total RNA was isolated from skin, spinal cord
and DRG using the RNeasy Mini Kit (Qiagen, Valencia,
CA) according to the manufacturer’s instructions. The
purity and concentration were determined spectrophoto-
metrically. The mRNA samples were reverse transcribed
into complementary DNA (cDNA) using a First Strand
cDNA Synthesis Kit (Invitrogen, Carlsbad, CA). Real-
time PCR was performed in an ABI prism 7900HT sys-
tem (Applied Biosystems, Foster City, CA). All PCR
experiments were performed using the SYBR Green I
master kit (Applied Biosystems). The primer sets for
C5aR and 18S mRNA and the amplification parameters
were described previously [10]. Melting curves were
performed to document single product formation and
agarose electrophoresis confirmed product size. The C5a
primers were purchased from SABiosciences
(SABiosciences, Valencia, CA). As negative controls,
RNA samples that were not reversibly transcribed were
run. Data were normalized by 18S mRNA expression.
Analysis of C5a in the skin
Skin tissue harvest and protein isolation
Mice were euthanized at the time points specified in the
figures. The skin tissue surrounding incision with
approximate 1.5 mm margins was excised, and skin
specimens were placed into phosphate-buffered saline
containing a protease inhibitor cocktail (Roche Com-
plete, Roche Diagnostics, Mannheim, Germany), and
frozen at -80°C until analysis. For protein isolation these
samples were first cut into small pieces with microscis-
sors then disrupted using a Polytron Device (Brinkmann
Instruments Inc, Westbury, NY). The samples were then
centrifuged at 10,000 rpm at 4°C for 10 min. The super-
natant was carefully pipetted into a fresh 1.5 ml tube,
which was the material used for protein analysis. Protein
concentration was evaluated with a DC Protein Assay
kit (Bio-Rad Laboratories, Hercules, CA).
C5a assessment
The complement anaphylatoxin C5a level in the skin of
the wound site was determined by a mouse C5a DuoSet
ELISA Kit according to the instruction provided by the
company (R&D Systems, Minneapolis, MN). Briefly, the
ELISA plate was coated with capture antibody, and fol-
lowed by washing with washing buffer. After blocking of
non-specific binding sites with blocking buffer, the plate
was incubated with 100 μl of each sample or C5a stan-
dard in duplicate. After incubation and subsequent
washing, detection antibody was added, followed by
washing and incubation with streptavidin-HRP at 400
ng/ml. Substrate Solution was added into each well for
the color reaction, and the reaction was stopped by
addition of stop solution and the absorbance read at 450
nm in microplate reader.
In vitro single fiber recordings
Preparation
One day after hairy skin incision or sham incision, mice
were killed using CO2 inhalation, and the hairy skin
from the dorso-medial hind paw was shaved and excised
with the innervating saphenous nerve. Attached connec-
tive tissue, muscle and tendon were removed. To ensure
a sufficient length of axon for recording, the nerve was
dissected up to the lumbar plexus. The dissected skin-
nerve preparation was fixed in a perfusion chamber with
the epidermal side down. The chamber was continu-
ously superfused with a “synthetic interstitial fluid” (SIF)
[25], a solution consisting (mM) of 107 NaCI, 26.2
NaHCO3, 9.64 sodium gluconate, 5.5 glucose, 7.6
sucrose, 3.48 KCI, I .67 NaH2PO4, 1.53 CaCl2, 0.69
MgSO4 at 31 ± 1°C, which was bubbled with a mixture
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of 95% O2 and 5% CO2. The nerve, attached to the
skin, was drawn through one small hole to the record-
ing chamber, which was filled with paraffin oil. The
nerve was placed on a fixed mirror, the sheath was
removed and nerve filaments repeatedly teased to
allow single fiber recordings to be made using plati-
num electrodes, one for recording and the other for
reference. The reference electrode was grounded to the
perfusion chamber. Single nociceptive afferent fibers
were recorded extracellularly with a differential ampli-
fier (DAM50, Harvard Apparatus, Holliston, MA).
Neural activity was amplified and filtered using stan-
dard techniques. Amplified signals were relayed to an
oscilloscope and an audio monitor and then into PC
computer via a data acquisition system (spike2/
CED1401 program). Action potentials collected on a
computer were analyzed off-line with a template
matching function of spike 2 software (version 4.24).
Fiber classification
The search strategy was mechanical stimulation by a
fire-polished glass rod; thus, all were mechanosensitive
fibers. The conduction velocity of the axon was deter-
mined by monopolar or bipolar electrical stimulation
through an epoxy-coated electrode with an uninsulated
tip. The supramaximal square wave pulses (0.2-2 ms
duration; 0.5 Hz) were delivered at the mechanosensitive
site of the receptive field. The distance between recep-
tive field and the recording electrode (conduction dis-
tance) was measured and divided by the latency of the
action potential. The single fibers were classified as
being either C- or A-fibers if their conduction velocity
was slower than 1.2 m/s or between 1.2 and 8.0 m/s,
respectively. The fast conducting (greater than 8.0 m/s)
and rapidly adapting fibers were excluded. In this study,
C-fibers were investigated for mechanical and heat
responses; A-fibers surrounding the incision were
included only for mechanical response experiments. In
previous experiments [11,13], C-fiber afferents with
receptive fields within 2 mm of the incision were sensi-
tized to heat and acid. We emphasized recording fibers
from sham control skin and fibers innervating ≤ 2 mm
from the incision. Some fibers from incised skin had




The mechanosensitive receptive field of each fiber was
isolated by placing a hollow metal cylinder with silicone
grease which was added to prevent leakage from the
bath into the receptive field. After a 2 min baseline
recording, the SIF solution inside the ring was replaced
with C5a (1 or 0.1 μg/ml) or PBS-vehicle in a 100 μl
volume and fiber activity was recorded for 2 min.
In other experiments, after a 2 min baseline recording,
the SIF solution inside the ring was replaced with
PMX53 1.8 μg/ml in a 50 μl volume. After a 2 min
exposure to PMX53, C5a 2 μg/ml or PBS-vehicle in a
50 μl volume was added into the ring so that the final
concentration of PMX53 was 0.9 μg/ml combined with
C5a 1 μg/ml (final concentration) or PBS-vehicle in a
total volume of 100 μl. Then fiber activity was recorded
for 2 min.
The fiber was considered activated by the drug if
activity of at least 0.1 impulse/s was elicited if back-
ground activity was absent during baseline recording, or
if ongoing activity was present, an increase of at least
two standard deviations greater than the average base-
line ongoing activity. For PMX53 application, some
fibers had ongoing activity. If ongoing activity was pre-
sent we noted if PMX53 decreased this activity. If the
average activity decreased by at least two standard
deviations from the baseline, it was considered a signifi-
cant decrease.
Heat responses
After ongoing activity of C-fibers was assessed, the test
solution inside the ring was aspirated to minimize heat
dissipation and a thermocouple was gently placed to
measure the subcutaneous temperature. A radiant heat
lamp was placed in the translucent area underneath the
organ bath and the light beam was focused onto the epi-
dermal side of the skin. After 10 s baseline recording, a
computer-controlled standard heat ramp was delivered
starting from 32 to 45°C over 15 s by a customized heat
stimulator (Bioengineering, University of Iowa, Iowa
City, IA). The peak temperature, 45°C, was used to
avoid potential tissue damage of higher temperatures.
We previously determined that the temperature of the
epidermal side was approximately 1°C higher than the
subdermal side. Fibers having a receptive field in a pre-
viously heated area were avoided for subsequent record-
ings. Each fiber was tested with heat only once because
previously we noted that repeated heating sensitized the
fiber responses. Action potentials were counted for 20 s
beginning from the onset of the heat, including the heat
ramp application (15 s) and 5 s after the peak tempera-
ture when the temperature remained elevated to 41°C,
for ‘during heat’ analysis. Action potentials between 20 s
and 60 s after the onset of the heat were also counted
for ‘after heat’ analysis that reflect after discharges fol-
lowing the stimulus. The temperature that elicited the
first action potential during heat stimulation was consid-
ered as threshold if background activity was absent. If
background activity was present, threshold was deter-
mined by the temperature during heating that increased
background activity at least two standard deviations
greater than the average baseline (10 s, 1 s bin). Back-
ground activity was subtracted from total action
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potential numbers during recording period, assuming
background activity was sustained during the heat
stimulus.
Mechanical responses
To avoid repeated application of drug for testing of heat
and mechanical stimuli, mechanical responses were
tested in separate experiments from heat. Servo-con-
trolled mechanical stimulation (Series 300B dual mode
servo system, Aurora Scientific, Canada) was used to
measure mechanosensitivity of C- and A-fibers. The
most sensitive spot of the receptive field of each fiber
was isolated with a metal cylinder as described above. A
flat and cylindrical metal probe (tip size 0.7 mm)
attached to the tip of stimulator arm was placed onto
the receptive field so that no force was generated. After
a 2 min baseline recording, a computer-controlled
ascending series of square force stimuli (5, 10, 20, 40
and 80 mN; 2 s duration; 60 s intervals) was applied to
the receptive field. Then, the SIF solution inside the ring
was replaced with C5a 1 μg/ml or PBS-vehicle solution
with 100 μl volume without any movement of the
mechanical probe or ring. After a 2 min drug applica-
tion, the same series of mechanical stimuli was applied
to the receptive field in the presence of applied drug. C-
fibers were tested regardless of location of the receptive
fields in relation to the incision; A-fibers ≤ 2 mm from
the incision were studied. The force that elicited the
first action potential during mechanical stimulation was
considered threshold if background activity was absent.
If background activity was present, threshold was deter-
mined by the force that increased activity by at least
two standard deviations greater than the average back-
ground. Background activity was subtracted from the
total number of action potentials during mechanical
stimulation.
Data analysis
Parametric and non-parametric analyses were selected
based on the Kolmogorov-Smirnov test for normal dis-
tribution (SigmaStat software. Jandel Corporation, San
Rafael, CA). For electrophysiological data, all data were
analyzed based on distances between receptive field and
incision site: sham vs. incision ≤ 2 mm vs. incision > 2
mm group based on our previous studies [11,13]. The
heat response threshold, and total action potentials dur-
ing and after heat stimulation were analyzed using t-test
(two groups) and one-way analysis of variance
(ANOVA) followed by Holm-Sidak correction (three
groups) for parametric data analysis, or Mann-Whitney
rank sum test (two groups) and Kruskall-Wallis
ANOVA followed by Dunn’s test (three groups) for
non-parametric data analysis. A chi-square test was used
to compare the percentage of fibers that had increased
ongoing activity or to evaluate the proportion of
afferents responding to heat and the proportion that
changed background activity. Analysis of the mechanical
stimulus-response relationship before and after drug was
performed using two-way repeated measures ANOVA.
Electrophysiological data for heat and mechanical data
are presented as median value and means ± SEM,
respectively. The behavioral and mRNA expression data
were analyzed by two-way ANOVA followed by Bonfer-
roni post-hoc test for multiple comparisons. Protein
analysis was done by one-way ANOVA followed by
Bonferroni post-hoc test for multiple comparisons.
Behavior data and the expression of mRNA and protein
are presented as means ± SEM. P values less than 0.05
were considered significant (Prism 4, GraphPad Soft-
ware, La Jolla, CA).
Results
Behavior
PMX53 suppresses heat hyperalgesia and mechanical
allodynia induced by hind paw incision
Heat hyperalgesia and mechanical allodynia are impor-
tant features of tissue injury related to surgery and
trauma [26,27]. Paw incision induced significant heat
hyperalgesia during the 72 hours following incision as
displayed in Figure 1A. However, local administrations
of the C5aR antagonist PMX53 via intraplantar injection
before and after incision significantly attenuated this
sensitization in comparison with the control group.
Likewise in our experiments, mechanical allodynia was
evident for the entire 72 hour period over which incised
mice were observed as shown as Figure 1B. Intraplantar
injection of PMX53 reduced the mechanical allodynia
from 48 to 72 hours after incision, but not at earlier
time points post incision.
PMX53 suppresses heat hyperalgesia and mechanical
allodynia induced by C5a
The results from the local injection of PMX53 suggest
that C5a present in skin can cause heat and mechanical
nociceptive sensitization. We attempted to confirm this
using local C5a injection. Intraplantar injection of
recombinant C5a induced significant heat hyperalgesia
lasting at least 6 hours as displayed in Figure 2A. The
peak level of sensitization was within the first 1 hour,
with the slow return to baseline at 24 hours after C5a
injection. However, pre-treatment with the PMX53 (3
mg/kg) largely abolished this heat sensitivity for the first
2 hours after C5aR agonist injection. Intraplantar injec-
tion of C5a significantly induced mechanical allodynia
along a time course similar to the heat effects as dis-
played in Figure 2B. The peak effect was reached within
0.5 hour after C5a injection, then slowly returned to the
baseline level at 24 hours. However, pre-treatment with
C5aR antagonist again prevented this sensitization for
about 2 hours after C5a injection.
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Figure 1 The effects of C5aR antagonist PMX53 on heat and mechanical nociception after incision. Intraplantar injection of PMX53
(30 μg/15 μl) reduced heat hyperalgesia and mechanical allodynia induced by hind paw incision (A and B, respectively). The first injection of
PMX53 was administered before paw incision, the second and subsequent administrations were made 2 hours prior to each test session.
For panels A and B values are expressed as mean ± SEM, *, P < 0.05 or ***, P < 0.001 compared to the control group. An arrow head at time
= 0 indicates incision.
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Figure 2 Pre-treatment with PMX53 (3 mg/kg) abolished the heat hyperalgesia (A) and mechanical allodynia (B) induced by
intraplantar injection of recombinant mouse C5a (200 ng). Values are expressed as mean ± SEM, *, P < 0.05, **, P < 0.01 or ***, P < 0.001
(comparison of C5a group and saline group); #, P < 0.05 (comparison of PMX53 group and saline group); ⋆⋆, P < 0.01 and ⋆⋆⋆, P < 0.001
(comparison of PMX53 and C5a groups). An arrow head at time = 0 indicates C5aR agonist injection.
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C5a and C5aR mRNA
Peri-incisional skin was analyzed for C5a and C5aR
expression (Figure 3A-F). The C5 mRNA in skin was
significantly increased as early as 2 h and reached the
peak at 48 h after incision. Also C5aR mRNA in skin
gradually increased after incision and peaked with a 7-
fold increase at 72 h. There were no significant changes
of C5 or C5aR mRNA in DRG or spinal cord samples
after incision.
C5a production in Skin
In the previous experiment we documented that C5a
precursor, C5 mRNA level was increased in the incised
skin. To further define the role of C5a in postsurgical
pain we established a mouse C5a ELISA procedure to
directly detect C5a production in the skin tissue. The
data in Figure 4 demonstrate that C5a production
increased in peri-incisional skin from 2 h at least 72 h
after the incision in comparison with control non-inci-
sion group (P < 0.001).
Single fiber recording
Ongoing activity
Application of PBS-vehicle did not increase ongoing
activity in C-fibers in the sham group (0/19) or in affer-
ents from the incised tissue with receptive fields ≤ 2
mm from the incision (0/22) (Figure 5A-D). C5a 1 μg/
ml increased ongoing activity in 4 of 21 (19.0%) C-fibers
in the sham group. Afferents from incised tissue were
similarly influenced; 3 of 23 (13.0%) C-fibers ≤ 2 mm
from the incision and 2 of 14 (14.2%) C-fibers > 2 mm
from the incision had increased activity. Similar to pre-
vious studies [6], C5a 0.1 μg/ml did not excite fibers in
the sham group (0/14); only 2 of 19 (10.5%) C-fibers ≤ 2
mm from the incision increased activity. A significant
difference (P = 0.034) was only observed in the propor-
tion of C-fibers activated by C5a 1 μg/ml (4/21, 19.0%),
C5a 0.1 μg/ml (0/14) and PBS-vehicle (0/19) in the
sham group; however, post hoc tests did not reveal a
significant difference of C5a vs. PBS-vehicle. No signifi-
cant difference was observed in the proportion of C-
fibers activated by C5a 1 μg/ml (3/23, 13.0%), C5a 0.1
μg/ml (2/19, 10.5%) and PBS-vehicle (0/22) that had
receptive fields ≤ 2 mm from the incision. Thus, there
was no evidence that more C-fibers were activated by
C5a in incised skin versus the sham preparations.
In this preparation, 14 of 38 (36.8%) fibers treated
with PBS-vehicle had significant spontaneous activity (at
least 0.1 impulse/s); activity decreased in 2 of 14 sponta-
neously active fibers (14.2%) after PBS-vehicle. Of those
exposed to PMX53 1.8 μg/ml, 9 of 42 (21.4%) fibers
were spontaneously active; only 3 of 9 spontaneously
active fibers (33.3%) decreased ongoing activity after
PMX53 application (data not shown). For all
spontaneously active C-fibers, regardless of proximity to
the incision, no differences were observed in the propor-
tion that decreased activity after PMX53 vs. PBS-vehicle.
Thus, there was no apparent contribution of C5a to this
ongoing activity that is present in vitro based on
responses to PMX53.
When C5a 1 μg/ml was applied after PMX53, 0 of 19
fibers with receptive field ≤ 2 mm from the incision and
only one fiber with receptive field > 2 mm from the
incision (1/10, 10.0%) increased ongoing activity (Figure
6A-E). PMX53 pre-treatment blocked C5a-induced exci-
tation (Figure 6). However, because few fibers were
directly excited by C5a (Figure 5); the difference in pro-
portion of fibers activated by C5a between the two
groups (control vs. PMX53) did not reach the statistical
significance (Figure 5vs. Figure 6).
Heat responses
In the sham group, C5a 1 μg/ml sensitized C-fibers to
heat (Figure 7A-M) by lowering the heat threshold and
increasing the number of action potentials during heat
stimulation compared to PBS-vehicle (Figure 7B and
7C). C5a 0.1 μg/ml had no effect. In C-fibers with
receptive fields ≤ 2 mm from the incision, C5a 1 μg/ml
and 0.1 μg/ml did not significantly sensitize responses
to heat versus PBS-vehicle (Figure 7F and 7G). In C-
fibers with receptive fields > 2 mm from the incision,
C5a 1 μg/ml sensitized C-fibers to heat by lowering the
heat threshold and increasing the number of action
potentials during heat stimulation (Figure 7J and 7K) as
in the sham tissue. The after heat responses were not
remarkable in any group (Figure 7D, H and 7L).
In the PBS-vehicle treated tissue, a high percentage of
C-fibers (49/57, 85.9%) in all groups responded to heat
(Figure 7E, I and 7M). There was no difference in the
proportion of fibers responding to heat among the sham
group and those with receptive fields ≤ 2 mm and > 2
mm from the incision. Almost all C-fibers (85/91,
93.4%) responded to heat after application of C5a (1 or
0.1 μg/ml), however, incision, compared to sham, did
not increase the heat responses to C5a or the propor-
tion of C-fibers responding to heat.
In C-fibers with receptive fields ≤ 2 mm from the inci-
sion (Figure 8A-E), the combination of PMX53 and
PBS-vehicle did not affect the heat responses of C-fibers
compared to PBS-vehicle alone (vehicle data from Figure
7F-I). When C5a 1 μg/ml was applied after PMX53, the
heat threshold, total number of action potentials during
and after heat stimulation, and the proportion of heat
responsive C-fibers were not different compared to PBS-
vehicle. Similarly, in the C-fibers with receptive fields >
2 mm from the incision (Figure 8F-I), C5a did not affect
heat responses (vs. PBS-vehicle, data from Figure 7J-M)
when the receptive fields were treated with PMX53.
Thus, PMX53 by itself did not affect heat responses of
Jang et al. Journal of Neuroinflammation 2011, 8:80
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Figure 3 Incision alters levels of C5 and C5aR after hind paw incision. Samples for C5 and C5aR mRNA analyses were collected at the
indicated time points. Data are displayed for peri-incisional skin (A and B), spinal cord (C and D) and DRG (E and F). For each tissue n = 4
samples, each analyzed in triplicate. Statistical comparisons were made between normalized baseline expression levels and those measured at
the indicated time points. Data are presented as mean ± SEM. *, P < 0.05, ***, P < 0.001.
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C-fibers with receptive fields ≤ 2 mm from the incision,
but inhibited heat sensitization induced by C5a in C-
fibers with receptive fields > 2 mm from the incision.
Mechanical response
The mechanical thresholds were not decreased by C5a 1
μg/ml or PBS-vehicle in C- or A-fibers from both sham
and the incision groups (Figure 9A-I). The median
mechanical thresholds of C-fibers before vs. after expo-
sure to C5a 1 μg/ml were as follows: sham (5 vs. 10
mN), incision ≤ 2 mm (15 vs. 7.5 mN) and incision > 2
mm (5 vs. 15 mN). Similarly, neither PBS-vehicle nor
C5a 1 μg/ml affected mechanical threshold of A-fibers
with receptive fields ≤ 2 mm from the incision. The
median values of threshold of A-fibers before vs. after
exposure to C5a 1 μg/ml, which had receptive fields ≤ 2
mm from the incision, were 20 vs. 40 mN. The stimulus
response functions were not enhanced by C5a 1 μg/ml
or PBS-vehicle. Incremental mechanical forces (5, 10,
20, 40 and 80 mN) applied on the receptive field elicited
greater responses. The activity during mechanical stimu-
lation was not influenced by PBS-vehicle or C5a 1 μg/
ml in C-fibers from sham or incised skin. Similarly,
neither PBS-vehicle nor C5a 1 μg/ml enhanced
responses to mechanical stimuli of A-fibers with recep-
tive fields ≤ 2 mm from the incision. Thus, the
responses to mechanical stimuli were not sensitized by
C5a vs. PBS-vehicle in C- or A-fibers from sham and
incised tissue.
Discussion
In this study, mRNA levels of C5 and C5aR, and C5a
protein in the skin were dramatically increased after
incision. Blockade of C5aR in vivo using a selective
C5aR antagonist, PMX53, decreased exogenous C5a-
induced heat and mechanical hypersensitivity. PMX53
alleviated incision-induced heat hypersensitivity at 24
hours and decreased mechanical hypersensitivity later at
48 hours. In vitro PMX53 blocked sensitization of
C-fiber afferents to heat by C5a but did not by itself
influence ongoing activity or heat sensitivity in afferents
innervating control or incised skin. C5a sensitized
C-fiber afferent responses to heat; this was less evident
in afferents adjacent to the incision. C5a did not elicit a
greater prevalence of increased ongoing activity in
Figure 4 C5a level in wounded skin was analyzed by a murine C5a ELISA. C5a level was significantly increased at the indicated time points
after incision in comparison with control group (time 0). Values are displayed as the mean ± SEM, n = 5, ***, P < 0.001.
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afferents from incised versus unincised control tissue.
The magnitude of mechanical responses was also not
affected by C5a in any nociceptive fibers innervating
incised or unincised skin. Altogether, high local concen-
trations of C5a contribute to enhanced behavioral
responses to heat 1 day after incision and also to
mechanical responses on day 2 and thereafter. High
local C5a expression rather than increased responsive-
ness of nociceptors to C5a contributes to hypersensitiv-
ity after incision.
Behavior responses
The hind paw incision induced heat and mechanical
hypersensitivity, and these hypersensitivities were signifi-
cantly attenuated by local blockade of C5aR in the hind
paw (Figure 1), highlighting the contribution of periph-
eral C5a to incisional pain. Heat, but not mechanical
sensitization was reduced by C5aR blockade early after
incision, i.e. within the first 24 hours. PMX53 was also
able to suppress behavioral hyperalgesia induced by
local injection of C5a (Figure 2). Hyperalgesia caused by
the application of other inflammatory mediators, e.g.
zymosan, carrageenan and lipopolysaccharide have also
been associated with C5aR activation [37]. Our studies
here suggest that at least at early time points, C5a alters
the heat sensitivity of C-fibers more markedly than
mechanical sensitivity. Apparently the contribution of
peripheral C5a signaling to mechanical sensitization is a
relatively minor contributor to sensitization early as
opposed to later times after incision. The contribution
Figure 5 Effects of C5a on ongoing activities of mechanosensitive C-fibers in incised tissue. (A) Example recordings of C-fibers with
receptive fields ≤ 2 mm from the incision before and after application of PBS-vehicle or C5a 1 μg/ml. Artifacts are produced during replacement
of solutions as marked. (B-D) Ongoing activities of C-fibers before and after exposure to C5a (1 or 0.1 μg/ml) or PBS-vehicle which have
receptive fields ≤ 2 mm (C) and > 2 mm (D) from the incision and in the sham group (B). Each line on the graphs represents a single unit. *
indicates an increase of ongoing activity after drug application. The small horizontal lines in each graph indicate median values.
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of central C5a in neuropathic pain has been suggested
[28,29]; however it remains to be determined whether it
also holds true for postoperative pain.
mRNA and protein expression
The mRNA levels of C5 and C5aR after incision were
locally plastic, but we did not find evidence for C5 system
plasticity within the DRG or central nervous systems (Fig-
ure 3). While C5 levels near incisions peak early and
remain elevated (Figure 3 and 4), local C5aR changes only
become significant at about 24 hours after incision.
Though we have shown C5a can act directly on afferent
fibers [6], we observed no increase in C5aR expression in
the DRG or spinal cord after incision. Thus, the up-regula-
tion of C5 and C5aR after incision appears to be locally
restricted, and perhaps related to the known expression of
C5/C5aR by neutrophils and intrinsic cells of the skin.
Electrophysiology
Application of C5a to nociceptive terminals directly acti-
vated few C-fibers in both sham and incised tissue
(Figure 5); therefore enhanced activation by C5a on inci-
sion is not evident. Based on the lack of effect of
PMX53 applied to the receptive field of spontaneously
active fibers (Figure 6), no significant contribution of
C5a to the ongoing activity in the incised skin nerve
preparation was observed.
In previous studies, incision sensitized nociceptors to
heat and lactic acid in skin [11,30]. Afferents in muscle
were also sensitized by incision; heat, mechanical and
acid responsiveness were enhanced compared to unin-
cised muscle [31]. It was surprising that incision did not
enhance the ability of C5a to sensitize C-fiber afferents
to heat or produced spontaneous activity. In fact
responses to C5a were not significantly different than
vehicle in afferents ≤ 2 mm from the incision. The lack
of significance may be due to the fact that some fibers
were already sensitized to heat by incision [30], and the
effects of additionally applied C5a on heat responses on
afferents adjacent to the incision may be saturated.
Because the heat responses (e.g. threshold and total
number of action potentials during and after heat) tend
Figure 6 Effects of PBS-vehicle and C5a applied after PMX53 on ongoing activities of mechanosensitive C-fibers in incised tissue. (A)
Example recordings of C-fibers with receptive fields ≤ 2 mm from the incision before and after application of PMX53 plus PBS-vehicle or PMX53
plus C5a 1 μg/ml. After recording of baseline, PMX53 1.8 μg/ml was applied, then PBS-vehicle or C5a was added to make the final concentration
of PMX53 0.9 μg/ml. Artifacts are produced during replacement of solutions as marked. (C and E) Ongoing activities of C-fibers before and after
exposure to PMX53 0.9 μg/ml plus PBS-vehicle or PMX53 0.9 μg/ml plus C5a 1 μg/ml which have receptive fields ≤ 2 mm (C) and > 2 mm (E)
from the incision. For comparison, PBS-vehicle data from Figure 5C and D are in used in Figure 6B and D. Each line on the graphs represents a
single unit. * indicates an increase in ongoing activity by drug application. Small horizontal lines in each graph indicate median values.
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to be sensitized in afferents adjacent to the incision
(Figure 7F-H), the study may be underpowered to detect
a further significant change by C5a. It is possible that
mechanically insensitive fibers contribute to heat hyper-
algesia in incised and control tissue as well. Some
mechanically insensitive fibers could become mechano-
sensitive after incision, and contribute to heat responses;
however, this can not be determined in this protocol.
Based on the heat responses after PMX53 application
alone (Figure 8), the C5aR does not contribute to heat
responses of C-fibers in the incised in vitro preparation.
C5a-induced mechanical hyperalgesia occurs in vivo in
naïve animals (Figure 2B). In the present study and in a
previous study, neither C-fibers (Figure 9C) nor A-fibers
sensitized to mechanical stimuli in sham control tissue
[6], and C5a did not affect mechanical responsiveness of
C- or A-fibers in skin from mice that had undergone
incision 24 h earlier (Figure 9). Mechanical hypersensi-
tivity may be secondary to other in vivo elements acti-
vated by complement which are removed in the skin
nerve preparation. Also, the brief treatment period
in vitro may not be sufficient to cause mechanical sensi-
tization that occurs as early as 30 min after complement
injection in vivo. Finally, because mechanical sensitiza-
tion of nociceptors has been less apparent than heat
sensitization in several studies, many propose that
mechanical hypersensitivity is in part due to sensitiza-
tion in the central nervous system [32].
The possible role of C5a in incisional pain
Based on observations that C5aR mRNA is expressed in
primary sensory neurons and the intracellular calcium
level is elevated by C5a treatment in cultured DRG neu-
rons in vitro [6], behavioral sensitization after incision
Figure 7 Effects of C5a on heat responses of mechanosensitive C-fibers in incised tissue. (A) Example recordings of C-fibers with receptive
fields ≤ 2 mm from the incision after application of PBS-vehicle or C5a 1 μg/ml. (B-D, F-H and J-L) Heat responses of C-fibers after exposure to
C5a (1 or 0.1 μg/ml) or PBS-vehicle which have receptive fields ≤ 2 mm (F-H) and > 2 mm (J-L) from the incision and in the sham group (B-D).
The proportion of C-fibers responsive to heat after application of each drug (E, I and M). Heat thresholds (B, F and J) and total action potentials
for 20 s during heat application (C, G and K) and 40 s after heat application (D, H and L). Each symbol represents a single unit. *, P < 0.05. **, P
< 0.01 vs PBS-vehicle. Data are presented as median values.
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could be caused by a direct binding of C5a to its periph-
eral receptors. At the same time, it is also possible that
C5a plays a role in incisional pain by indirect mechan-
isms. C5a is one of the most potent inflammatory mole-
cules known to induce proinflammatory functions such
as upregulation of cytokine and chemokine production,
and it is also a strong chemoattractant for neutrophils,
monocytes and macrophages that can release a mixture
of algogenic substances, e.g. histamine, interleukins,
TNF-a and others [1-4,33,34] which produce heat and
mechanical hyperalgesia when injected into hind paw
[35-41]. In support, mRNA levels of peripheral C5 and
C5aR were markedly increased in the incised skin but
not DRG or spinal cord after incision (Figure 3), imply-
ing the recruitment of inflammatory cells to the incision
site. Our previous study showed several locally produced
cytokines from incisions were dependent on C5aR [10].
Thus, these indirect effects of C5a on nociceptive sensi-
tization may be as important as the effects of C5a itself
on sensory neurons.
Additionally, activation of small diameter nociceptors
by C5a may contribute to behavioral sensitization by
releasing various algesic substances e.g. glutamate,
neuropeptides and ATP in the peripheral and central
terminals to sensitize dorsal horn neurons [42-45] and
nociceptors [46-50]. However, this does not occur
immediately after application to skin in vitro. It is possi-
ble that application of C5a for several hours in vitro
could induce mechanical sensitization; however, this can
not be tested.
Conclusions
In summary, treatment with a selective C5aR
antagonist, PMX-53, decreased heat and mechanical
hypersensitivity induced by incision or by local admin-
istration of C5a in vivo. The increase of C5a protein
level in the incised skin was observed. The mRNA
levels of C5 and C5aR in the skin were increased after
incision, but not in the DRG and spinal cord. The sen-
sitivity of nociceptors to C5a was not significantly
enhanced by incision in vitro. Therefore, the reduced
hypersensitivity resulting from PMX53 administration
in vivo is caused by blockade of receptor activation
produced by high local concentrations of C5a. In the
future, the effect of drugs like PMX53 on clinical post-
operative pain could be considered.
Figure 8 Effects of PMX53 pre-treatment on heat responses of mechanosensitive C-fibers in incised tissue. (A) Example recordings of C-
fibers with receptive fields ≤ 2 mm from the incision after application of PMX53 0.9 μg/ml plus PBS-vehicle or PMX53 0.9 μg/ml plus C5a 1 μg/
ml. (B-D and F-H) Heat responses of C-fibers after exposure to PMX53 0.9 μg/ml plus PBS-vehicle or PMX53 0.9 μg/ml plus C5a 1 μg/ml which
have receptive fields ≤ 2 mm (B-D) and > 2 mm (F-H) from the incision. The proportion of C-fibers responsive to heat after application of each
drug (E and I). Heat thresholds (B and F) and total action potentials for 20 s during heat application (C and G) and 40 s after heat application (D
and H). PBS-vehicle data B-I are from Figure 7F-M. Each symbol represents a single unit. Data are presented as median values.
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Figure 9 Effects of C5a on mechanical responses of mechanosensitive C- and A-fibers in incised tissue. (A) Example recordings of C-fibers
with receptive fields ≤ 2 mm from the incision before and after application of PBS-vehicle or C5a 1 μg/ml. (B-G) Mechanical thresholds (left
panels) and stimulus response function (right panels) of C-fibers before and after exposure to PBS-vehicle or C5a 1 μg/ml which have receptive
fields ≤ 2 mm (D and E) and > 2 mm (F and G) from the incision and in sham group (B and C). (H and I) Mechanical thresholds (left panels) and
stimulus response function (right panels) of A-fibers before and after exposure to PBS-vehicle or C5a 1 μg/ml which have receptive fields ≤ 2
mm from the incision. In left panels, each line represents a single unit, and the small horizontal lines in each graph indicate median values. In
right panels, data are presented as means ± SEM.
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